0001209191-22-044465.txt : 20220804 0001209191-22-044465.hdr.sgml : 20220804 20220804203955 ACCESSION NUMBER: 0001209191-22-044465 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220802 FILED AS OF DATE: 20220804 DATE AS OF CHANGE: 20220804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Perfetti Riccardo CENTRAL INDEX KEY: 0001775410 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38898 FILM NUMBER: 221138328 MAIL ADDRESS: STREET 1: C/O APPLIED THERAPEUTICS, INC. STREET 2: 340 MADISON AVENUE, 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10173 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Applied Therapeutics Inc. CENTRAL INDEX KEY: 0001697532 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-220-9319 MAIL ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-02 0 0001697532 Applied Therapeutics Inc. APLT 0001775410 Perfetti Riccardo C/O APPLIED THERAPEUTICS, INC. 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 0 1 0 0 Chief Medical Officer Employee Stock Option (Right to Buy) 2.02 2022-08-02 4 D 0 50000 D 2032-04-13 Common Stock 50000 0 D Employee Stock Option (Right to Buy) 1.05 2022-08-02 4 D 0 50000 A 2032-04-13 Common Stock 50000 50000 D Employee Stock Option (Right to Buy) 4.17 2022-08-02 4 D 0 32100 D 2032-01-07 Common Stock 32100 0 D Employee Stock Option (Right to Buy) 1.05 2022-08-02 4 D 0 32100 A 2032-01-07 Common Stock 32100 32100 D Employee Stock Option (Right to Buy) 9.44 2022-08-02 4 D 0 32100 D 2031-12-14 Common Stock 32100 0 D Employee Stock Option (Right to Buy) 1.05 2022-08-02 4 D 0 32100 A 2031-12-14 Common Stock 32100 32100 D Employee Stock Option (Right to Buy) 23.15 2022-08-02 4 D 0 36495 D 2030-12-10 Common Stock 36495 0 D Employee Stock Option (Right to Buy) 1.05 2022-08-02 4 D 0 36495 A 2030-12-10 Common Stock 36495 36495 D Employee Stock Option (Right to Buy) 22.20 2022-08-02 4 D 0 51666 D 2029-12-16 Common Stock 51666 0 D Employee Stock Option (Right to Buy) 1.05 2022-08-02 4 D 0 51666 A 2029-12-16 Common Stock 51666 51666 D Employee Stock Option (Right to Buy) 10.00 2022-08-02 4 D 0 134997 D 2029-05-12 Common Stock 134997 0 D Employee Stock Option (Right to Buy) 1.05 2022-08-02 4 D 0 134997 A 2029-05-12 Common Stock 134997 134997 D The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. Reflects an initial grant of 50,000 Options granted on April 13, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date. Reflects an initial grant of 32,100 Options granted on January 7, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date. Reflects an initial grant of 32,100 Options granted on December 14, 2021 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on December 14, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date. Reflects an initial grant of 36,495 Options granted on December 10, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date. Reflects an initial grant of 51,666 Options granted on December 16, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 16, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date. Reflects an initial grant of 170,522 Options granted on May 13, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on May 13, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. /s/ Shoshana Shendelman, as attorney-in-fact 2022-08-04